Patients with breast cancer at long-term increased risk of first depression
the ONA take:
According to a new study published in Journal of Clinical Oncology, women with breast cancer are at an increased long-term risk for developing first depression.
The researchers sought to investigate the risk of first depression by determining the incidence of hospital contact as a result of severe episodes of depression and the incidence of antidepressant use. Researchers used Danish national registries to identify nearly 2 million women no diagnosis of cancer or a major psychiatric disorder.
Researchers followed these patients from 1998 and 2011. In the 13-year time period, nearly 45,000 women were diagnosed with breast cancer. Within 1 year after cancer diagnosis, hospital contact had a rate ratio of 1.70 (95% CI, 1.41 - 2.05) and antidepressant use had a rate ratio of 3.09 (95% CI, 2.95 - 3.22). At 3 and 8 years, both rate ratios were significantly elevated.
The researchers also identified various factors associated with the use of antidepressants, including basic and vocational education levels, comorbidity, living alone, node-positive disease, and older age, which the researchers recommend clinicians be aware of.
Women with breast cancer are at an increased long-term risk for developing first depression.
Purpose of this study is to investigate the risk for first depression, assessed as incident hospital contacts for depression and incident use of antidepressants, among women with breast cancer. Women with breast cancer are at long–term increased risk for first depression, including both severe episodes leading to hospital contact and use of antidepressants.
Clinicians should be aware that the risk is highest in women with comorbid conditions, node–positive disease, and age of 70 years or more. The authors found no clear association between type of surgery or adjuvant treatment and risk for depression.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|